Back
First Trust NASDAQ Technology Dividend Index Fund Vs. Madrigal Pharmaceuticals, Inc. Industry Stock Comparison
Sell
39
TDIV
First Trust NASDAQ Technology Dividend Index Fund
Last Price:
$96.99
Seasonality Move:
1.23%
Buy
64
MDGL
Madrigal Pharmaceuticals, Inc.
Last Price:
$554.50
Seasonality Move:
13.5%
Sell
39
First Trust NASDAQ Technology Dividend Index Fund (TDIV)
is a Sell
Is First Trust NASDAQ Technology Dividend Index Fund a Buy, Sell or Hold?
-
The current First Trust NASDAQ Technology Dividend Index Fund [TDIV] share price is $97.51. The Score for TDIV is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
-
TDIV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Madrigal Pharmaceuticals, Inc. (MDGL)
is a Buy
Is Madrigal Pharmaceuticals, Inc. a Buy, Sell or Hold?
-
The current Madrigal Pharmaceuticals, Inc. [MDGL] share price is $571.44. The Score for MDGL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
-
MDGL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
TDIV Stock Price Chart
What is First Trust NASDAQ Technology Dividend Index Fund's stock price today?
-
The First Trust NASDAQ Technology Dividend Index Fund share price today is $97.51The current trend is moderately bearish and TDIV is experiencing selling pressure, which indicates risk of future bearish movement.
MDGL Stock Price Chart
What is Madrigal Pharmaceuticals, Inc.'s stock price today?
-
The Madrigal Pharmaceuticals, Inc. share price today is $571.44The current trend is moderately bullish and MDGL is experiencing slight buying pressure.
TDIV Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.76 | Buy |
| Relative Strength Index (14 RSI): | 47.25 | Sell |
| Chaikin Money Flow: | -60538 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (94.61 - 99.79) | Buy |
| Bollinger Bands (100): | (92.46 - 100.02) | Buy |
MDGL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 20 | Buy |
| Relative Strength Index (14 RSI): | 59.62 | Buy |
| Chaikin Money Flow: | 50743 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (528.97 - 586.99) | Buy |
| Bollinger Bands (100): | (367.46 - 524.18) | Buy |
TDIV Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 100 | Sell |
| 20-day SMA: | 97.13 | Buy |
| 50-day SMA: | 98.56 | Sell |
| 200-day SMA: | 88.14 | Buy |
| 8-day EMA: | 99.47 | Sell |
| 20-day EMA: | 98.48 | Sell |
| 50-day EMA: | 95.89 | Buy |
| 200-day EMA: | 59.89 | Buy |
MDGL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 570.14 | Buy |
| 20-day SMA: | 568.95 | Buy |
| 50-day SMA: | 496.62 | Buy |
| 200-day SMA: | 377.22 | Buy |
| 8-day EMA: | 568.69 | Buy |
| 20-day EMA: | 556.87 | Buy |
| 50-day EMA: | 511.83 | Buy |
| 200-day EMA: | 403.9 | Buy |
First Trust NASDAQ Technology Dividend Index Fund Earnings Growth & TDIV Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Madrigal Pharmaceuticals, Inc. Earnings Growth & MDGL Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.88 per share, a decrease next quarter of $0.00 per share, an increase this year of $12.45 per share, and an increase next year of $15.15 per share.
First Trust NASDAQ Technology Dividend Index Fund Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Madrigal Pharmaceuticals, Inc. Technical Analysis
| Dec 1 | Dec 2 | Dec 3 | Dec 4 | Dec 5 | Dec 8 | Dec 9 | Dec 10 | Dec 11 | Dec 12 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 01 | 02 | 03 | 04 | 05 | 08 | 09 | 10 | 11 | 12 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||